Category: Finance
-
SmartMetric’s Dominance in Biometric Credit Card Technology and Its Unrivalled Patent Power
In the realm of financial technology, the constant quest for improved security and efficiency has led to remarkable innovations. Today, we highlight one such groundbreaking development: SmartMetric, Inc.’s (OTC: SMME) biometric fingerprint activated credit cards. After dedicating over a decade to research and development, the company is finally gearing up to introduce its unique solution…
-
Artificial Intelligence Technology Solutions, Inc. (AITX) Secures Multiple Orders via Subsidiary Robotic Assistance Devices (RAD)
Artificial Intelligence Technology Solutions, Inc. (AITX), through its wholly owned subsidiary, Robotic Assistance Devices (RAD), has made a significant breakthrough in the artificial intelligence (AI) security space. The company has managed to secure two significant orders from one of RAD’s largest authorized dealers for an array of security solutions, including 11 ROSA™ security devices, 6…
-
Vortex Brands Announces 33% Increase to Its Quarterly Cash Dividend
News provided by Vortex Brands Co. 20 Jun, 2023, 08:30 ET DENVER, June 20, 2023 /PRNewswire/ — Vortex Brands Co. (OTC: VTXB), a leading provider of cryptocurrency mining services, is excited to announce a quarterly cash dividend for its shareholders derived from its successful Bitcoin mining operations. The dividend payment was increased by 33% to…
-
Owlet Steps Up with FDA-Cleared, Prescription Pulse Oximetry Sock for Infants: A Game Changer in Baby Care
Tue, June 20, 2023 The world of infant healthcare is in for a transformational shift, led by Owlet (NYSE: OWLT), a trailblazer in smart baby monitoring technology. The company’s stock witnessed a surge of 11.5600% as it announced its recent achievement: gaining FDA-clearance for BabySat™, the very first wire-free, prescription pulse oximetry sock designed for…
-
Faraday Future’s Reverse Stock Split – A Bold Step for Financing Opportunities and Enhanced Production
Hello to all the investors, market analysts, and EV enthusiasts who are part of this blog. Today, we have a significant announcement from Faraday Future Intelligent Electric Inc. (Nasdaq: FFIE), popularly known as Faraday Future or FF. The California-based global shared intelligent electric mobility ecosystem company is about to embark on a new venture. The…
-
Lumen Technologies in Tandem with Google and Microsoft Unveils ExaSwitch: A Future-Proof Interconnection Ecosystem
Lumen Technologies (NYSE: LUMN) recently announced the creation of an innovative network interconnection ecosystem, the ExaSwitch™, developed in collaboration with tech giants Google and Microsoft. A disruptive step forward, ExaSwitch™ provides organizations with high bandwidth requirements the ability to route their traffic dynamically between networks without the need for third-party intervention. This on-demand optical interconnection…
-
SPAC Merger Alert – ANEW Medical and Redwoods Acquisition Corp. Ink Definitive Agreement
Hello and welcome fellow investors! Today, I am thrilled to dive deep into the significant announcement that recently shook the financial markets. We are talking about the definitive merger agreement between ANEW MEDICAL INC. (OTC: LEAS) and Redwoods Acquisition Corp. (NASDAQ: RWOD). This strategic alliance could potentially become a game changer in the field of…
-
Enzolytics’ (ENZC) Virogentics and Biogenysis Sale Transaction, Clinical Trials Progress, and Arican ITV-1 Project Updates: A Closer Look
June 5, 2023. An impressive stride in the biotech industry is made as Enzolytics, Inc. – a pioneer in drug development and a beacon of hope for debilitating infectious diseases – shares updates about the sale of its wholly-owned subsidiaries, Virogentics, Inc. and Biogenysis, Inc., as well as details regarding its ongoing clinical trials approved…
-
Monopar Therapeutics Progress: A Signal for Potential Trend Reversal
Monopar Therapeutics Inc. (MNPR), a clinical-stage biopharmaceutical company, recently announced encouraging updates from its ongoing Phase 1b clinical trial of camsirubicin for advanced soft tissue sarcoma (ASTS) patients. These updates, coupled with a favorable technical chart pattern and rising optimism among Wall Street analysts, could signal a potential trend reversal for the stock that has…
-
Opendoor Grants Over 5 Million Restricted Stock Units and Announces Q1 2023 Financial Results
In a significant announcement, Opendoor Technologies Inc. (“Opendoor”) (Nasdaq: OPEN), a prominent e-commerce platform specializing in residential real estate transactions, has granted restricted stock units covering 5,073,831 shares of its common stock to thirty-three (33) non-executive employees. The award took place on May 23, 2023, under the 2022 Inducement Award Plan (the “Inducement Plan”), as…